FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W190438250> ?p ?o ?g. }

• W190438250 endingPage "757" @default.
• W190438250 startingPage "749" @default.
• W190438250 abstract "Abstract It has been reported that in many neoplastic diseases, including leukemia, alterations in plasma zinc levels may frequently occur, although the causes for such alterations have yet to be clearly defined. Since zinc is required to induce biological activity to thymulin (Zn-FTS), a biochemical defined thymic hormone, and marginal zinc deficiencies may prevent its peripheral biological activation, we investigated the plasma level of zinc and of both active thymulin (Zn- FTS) and total zinc saturable thymulin (Zn-FTS + FTS) in 91 young patients affected by acute lymphoblastic leukemia (ALL) at various stages of the disease. It was discovered that the plasma zinc level was reduced at the onset and relapse, whereas in complete remission and in off-therapy it was in the normal range. Total zinc-saturable thymulin concentration did not change during the disease, whereas the active fraction was reduced at the onset and in relapse when compared with values observed in the other stages of the disease or in healthy controls. These data suggest that zinc plasma deficiency is present in ALL patients at the onset and during relapse, and that such a deficiency causes a decrease in the activity of thymulin despite a nearly normal production by the thymus. An impairment of peripheral immune efficiency in ALL patients is commonly found. The existence of positive correlations between zinc or active thymulin and peripheral immunological parameters (phytohemagglutinin [PHA] and concanavalin A [ConA]) at various stages of the disease suggests a link between derangement of peripheral immune function, thymic hormone activity, and zinc failure. These findings, considered together, suggest the possibility of a carefully controlled clinic trial with zinc in ALL patients at the onset and in relapse even in the light of in vitro ineffectiveness of physiological zinc or thymulin concentrations on the duplicative index of human lymphoblastoid cells." @default.
• W190438250 created "2016-06-24" @default.
• W190438250 creator A5044604788 @default.
• W190438250 creator A5045492351 @default.
• W190438250 creator A5062523604 @default.
• W190438250 creator A5062631717 @default.
• W190438250 creator A5073523995 @default.
• W190438250 creator A5086502114 @default.
• W190438250 date "1994-02-01" @default.
• W190438250 modified "2023-09-26" @default.
• W190438250 title "Plasma zinc level and thymic hormone activity in young cancer patients" @default.
• W190438250 cites W1600440224 @default.
• W190438250 cites W1637471905 @default.
• W190438250 cites W1673959982 @default.
• W190438250 cites W1954500581 @default.
• W190438250 cites W1970774076 @default.
• W190438250 cites W1977197539 @default.
• W190438250 cites W1981257284 @default.
• W190438250 cites W1986544770 @default.
• W190438250 cites W1992699376 @default.
• W190438250 cites W2002299348 @default.
• W190438250 cites W2017201358 @default.
• W190438250 cites W2041172576 @default.
• W190438250 cites W2042256294 @default.
• W190438250 cites W2046833490 @default.
• W190438250 cites W2055758852 @default.
• W190438250 cites W2056331361 @default.
• W190438250 cites W2058830606 @default.
• W190438250 cites W2061829192 @default.
• W190438250 cites W2071635262 @default.
• W190438250 cites W2072883983 @default.
• W190438250 cites W2076338201 @default.
• W190438250 cites W2077647252 @default.
• W190438250 cites W2086875701 @default.
• W190438250 cites W2091783147 @default.
• W190438250 cites W2095378223 @default.
• W190438250 cites W2133516396 @default.
• W190438250 cites W2163923345 @default.
• W190438250 cites W2312204048 @default.
• W190438250 cites W2316319572 @default.
• W190438250 cites W2324461246 @default.
• W190438250 cites W2407061276 @default.
• W190438250 cites W2410733622 @default.
• W190438250 cites W2422689941 @default.
• W190438250 cites W2505574404 @default.
• W190438250 cites W88778487 @default.
• W190438250 cites W2188572022 @default.
• W190438250 cites W2492081416 @default.
• W190438250 cites W303080625 @default.
• W190438250 doi "https://doi.org/10.1182/blood.v83.3.749.749" @default.
• W190438250 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8298137" @default.
• W190438250 hasPublicationYear "1994" @default.
• W190438250 type Work @default.
• W190438250 sameAs 190438250 @default.
• W190438250 citedByCount "37" @default.
• W190438250 countsByYear W1904382502012 @default.
• W190438250 countsByYear W1904382502013 @default.
• W190438250 countsByYear W1904382502016 @default.
• W190438250 countsByYear W1904382502023 @default.
• W190438250 crossrefType "journal-article" @default.
• W190438250 hasAuthorship W190438250A5044604788 @default.
• W190438250 hasAuthorship W190438250A5045492351 @default.
• W190438250 hasAuthorship W190438250A5062523604 @default.
• W190438250 hasAuthorship W190438250A5062631717 @default.
• W190438250 hasAuthorship W190438250A5073523995 @default.
• W190438250 hasAuthorship W190438250A5086502114 @default.
• W190438250 hasBestOaLocation W1904382501 @default.
• W190438250 hasConcept C126322002 @default.
• W190438250 hasConcept C134018914 @default.
• W190438250 hasConcept C178790620 @default.
• W190438250 hasConcept C185592680 @default.
• W190438250 hasConcept C19869320 @default.
• W190438250 hasConcept C202751555 @default.
• W190438250 hasConcept C203014093 @default.
• W190438250 hasConcept C2776928490 @default.
• W190438250 hasConcept C2778461978 @default.
• W190438250 hasConcept C46762472 @default.
• W190438250 hasConcept C535196362 @default.
• W190438250 hasConcept C55493867 @default.
• W190438250 hasConcept C71315377 @default.
• W190438250 hasConcept C71924100 @default.
• W190438250 hasConcept C8891405 @default.
• W190438250 hasConceptScore W190438250C126322002 @default.
• W190438250 hasConceptScore W190438250C134018914 @default.
• W190438250 hasConceptScore W190438250C178790620 @default.
• W190438250 hasConceptScore W190438250C185592680 @default.
• W190438250 hasConceptScore W190438250C19869320 @default.
• W190438250 hasConceptScore W190438250C202751555 @default.
• W190438250 hasConceptScore W190438250C203014093 @default.
• W190438250 hasConceptScore W190438250C2776928490 @default.
• W190438250 hasConceptScore W190438250C2778461978 @default.
• W190438250 hasConceptScore W190438250C46762472 @default.
• W190438250 hasConceptScore W190438250C535196362 @default.
• W190438250 hasConceptScore W190438250C55493867 @default.
• W190438250 hasConceptScore W190438250C71315377 @default.
• W190438250 hasConceptScore W190438250C71924100 @default.
• W190438250 hasConceptScore W190438250C8891405 @default.
• W190438250 hasIssue "3" @default.

• next